期刊
CURRENT OPINION IN BIOTECHNOLOGY
卷 68, 期 -, 页码 51-59出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2020.09.012
关键词
-
Endolysins, as a promising new class of antimicrobials, have shown effectiveness in various animal models against bacterial infections in different organs and tissues. However, challenges such as immunogenicity, circulation half-life, and specific targeting and penetration properties still need to be addressed for their systemic application.
The rapid emergence of antibiotic-resistant bacteria and the lack of novel antibacterial agents pose a serious threat for patients and healthcare systems. Bacteriophage-encoded peptidoglycan hydrolases (endolysins) represent a promising new class of antimicrobials. Over the past two decades, research on these enzymes has evolved from basic in vitro characterization to sophisticated protein engineering approaches, including advanced preclinical and clinical testing. In recent years, increasingly specific animal models have shown efficacy of endolysins against bacterial infections of various different organs and tissues of the body. Despite these advances, some challenges with regard to systemic application of endolysins remain to be addressed. These include immunogenicity, circulation half-life, and cell and tissue-specific targeting and penetration properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据